Gregg Williams - Second Sight Independent Director
EYESDelisted Stock | USD 4.14 0.20 4.61% |
Director
Mr. Gregg Williams is Chairman of the Board of the Company. Mr. Williams has served as a member of our Board of Directors since June 2009 and was appointed Chairman of our board in March 2018. Mr. Williams serves as the Chief Executive Officer at Williams International, a leading developer and manufacturer of small gas turbine engines, since April 2005 since 2018.
Age | 58 |
Tenure | 6 years |
Phone | 818 833-5000 |
Web | www.secondsight.com |
Second Sight Management Efficiency
The company has return on total asset (ROA) of (10.74) % which means that it has lost $10.74 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (19.02) %, meaning that it created substantial loss on money invested by shareholders. Second Sight's management efficiency ratios could be used to measure how well Second Sight manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 199 K in liabilities with Debt to Equity (D/E) ratio of 0.0, which may suggest the company is not taking enough advantage from borrowing. Second Sight Medical has a current ratio of 24.75, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Second Sight until it has trouble settling it off, either with new capital or with free cash flow. So, Second Sight's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Second Sight Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Second to invest in growth at high rates of return. When we think about Second Sight's use of debt, we should always consider it together with cash and equity.
Similar Executives
Showing other executives | DIRECTOR Age | ||
Gilbert Harrison | Inter Parfums | 76 | |
Sophie Gasperment | Cimpress NV | 53 | |
Patrice Lucas | United Guardian | N/A | |
Peter Gyenes | Cimpress NV | 69 | |
Elizabeth Long | Edgewell Personal Care | 67 | |
Daniel Heinrich | Edgewell Personal Care | 64 | |
Eric Olsen | Cimpress NV | 52 | |
Robert BensoussanTorres | Inter Parfums | 60 | |
Robert Rubinger | United Guardian | 75 | |
George Corbin | Edgewell Personal Care | 56 | |
Axel Marot | Inter Parfums | 42 | |
Michel Dyens | Inter Parfums | 78 | |
Mark Thomas | Cimpress NV | 63 | |
Zachary Sternberg | Cimpress NV | 32 | |
Philippe Santi | Inter Parfums | 56 | |
Lawrence Maietta | United Guardian | 60 | |
Emmanuel Delay | United Guardian | N/A | |
Scott Vassalluzzo | Cimpress NV | 46 | |
Gary Waring | Edgewell Personal Care | 61 | |
Paolo Cesare | Cimpress NV | 57 | |
Jean Levy | Inter Parfums | 83 |
Management Performance
Return On Equity | -19.02 | |||
Return On Asset | -10.74 |
Second Sight Medical Leadership Team
Elected by the shareholders, the Second Sight's board of directors comprises two types of representatives: Second Sight inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Second. The board's role is to monitor Second Sight's management team and ensure that shareholders' interests are well served. Second Sight's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Second Sight's outside directors are responsible for providing unbiased perspectives on the board's policies.
John Blake, CFO | ||
Patrick Ryan, COO | ||
Frank Vandeputte, Vice President General Manager | ||
Anthony Moses, Commercial Vice President - Americas | ||
Edward Randolph, VP of Manufacturing | ||
Gregg Williams, Independent Director | ||
Alfred Mann, Co-Founder, Chairman Emeritus, Member of Audit Committee, Member of Nominating and Governance Committee and Member of Compensation Committee | ||
Jonathan McGuire, President CEO, Director | ||
Stephen Okland, Commercial Vice President U.S. and Canada | ||
Gregoire Cosendai, VP of European Operations | ||
Steven Okland, Commercial Vice President U.S. and Canada | ||
William Link, Independent Director | ||
Thomas Miller, CFO | ||
James Miller, Director - Manufacturing | ||
Will McGuire, President CEO, Director | ||
David Jacques, Vice President - Research & Development | ||
Aaron Mendelsohn, Director | ||
Robert Greenberg, President CEO, Director | ||
Matthew Pfeffer, Independent Director |
Second Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Second Sight a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -19.02 | |||
Return On Asset | -10.74 | |||
Current Valuation | 11.54 M | |||
Shares Outstanding | 39.41 M | |||
Shares Owned By Insiders | 28.61 % | |||
Shares Owned By Institutions | 7.01 % | |||
Number Of Shares Shorted | 1.19 M | |||
Price To Earning | (1.61) X | |||
Price To Book | 0.93 X | |||
Price To Sales | 616.54 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Second Sight in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Second Sight's short interest history, or implied volatility extrapolated from Second Sight options trading.
Pair Trading with Second Sight
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Second Sight position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Second Sight will appreciate offsetting losses from the drop in the long position's value.Moving together with Second Stock
0.74 | MDT | Medtronic PLC Financial Report 23rd of May 2024 | PairCorr |
Moving against Second Stock
0.63 | BSX | Boston Scientific Corp Earnings Call Tomorrow | PairCorr |
0.53 | EW | Edwards Lifesciences Corp Earnings Call This Week | PairCorr |
0.5 | DXCM | DexCom Inc Earnings Call This Week | PairCorr |
0.5 | ALGN | Align Technology Earnings Call Tomorrow | PairCorr |
0.45 | LRDG | Lord Global Corp | PairCorr |
The ability to find closely correlated positions to Second Sight could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Second Sight when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Second Sight - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Second Sight Medical to buy it.
The correlation of Second Sight is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Second Sight moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Second Sight Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Second Sight can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the Second Sight Medical information on this page should be used as a complementary analysis to other Second Sight's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Consideration for investing in Second Stock
If you are still planning to invest in Second Sight Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Second Sight's history and understand the potential risks before investing.
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Fundamental Analysis View fundamental data based on most recent published financial statements |